Compile Data Set for Download or QSAR
Report error Found 114 Enz. Inhib. hit(s) with all data for entry = 13259
TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771667(2-(4-(2-(4-chloro- 2-fluorophenyl)-2- methylbenzo[...)
Affinity DataEC50:  0.0150nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771674(2-(4-(2-(4-chloro- 2-fluorophenyl)-2- methylbenzo[...)
Affinity DataEC50:  0.0240nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771696(2-(4-(2-(4-chloro- 2-fluorophenyl)-2- methylbenzo[...)
Affinity DataEC50:  0.0330nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771680(2-(4-(2-(4-chloro- 2-fluorophenyl)-2- methylbenzo[...)
Affinity DataEC50:  0.0340nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771699(2-(4-(2(4-chloro- 2-fluorophenyl)-2- methylbenzo[d...)
Affinity DataEC50:  0.0700nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771681(2-(4-(2-(5- chloropyridin-2- yl)-2- methylbenzo[d]...)
Affinity DataEC50:  0.0760nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771672(2-(4-(2-(4-chloro- 2-fluorophenyl)-2- methylbenzo[...)
Affinity DataEC50:  0.0890nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771670(2-(4-(2-(4-chloro- 2-fluorophenyl)-2- methylbenzo[...)
Affinity DataEC50:  0.140nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771654(2-(4-(2-(4-chloro-2-fluorophenyl)-2-methylbenzo[d]...)
Affinity DataEC50:  0.170nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771697(2-(4-(2-(5- chloropyridin-2- yl)-2- methylbenzo[d]...)
Affinity DataEC50:  0.190nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771742(2-(4-(2-(4-cyano- 2-fluorophenyl)-2- methylbenzo[d...)
Affinity DataEC50:  0.230nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771677(2-(4-(2-(4-cyano- 2-fluorophenyl)-2- methylbenzo[d...)
Affinity DataEC50:  0.300nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771701(2-(4-(2-(5- chloropyridin-2- yl)-2- methylbenzo[d]...)
Affinity DataEC50:  0.310nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771746(2-(4-(2-(4-cyano- 2-fluorophenyl)-2- methylbenzo[d...)
Affinity DataEC50:  0.320nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771665(2-(4-(2-(4-chloro- 2-fluorophenyl)-2- methylbenzo[...)
Affinity DataEC50:  0.410nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771675(2-(4-(2-(4-chloro- 2-fluorophenyl)-2- methylbenzo[...)
Affinity DataEC50:  0.490nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771653(2-(4-(2-(4-chloro- 2-fluorophenyl)-2- methylbenzo[...)
Affinity DataEC50:  0.510nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771745(2-(4-(2-(4-cyano- 2-fluorophenyl)-2- methylbenzo[d...)
Affinity DataEC50:  0.520nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771679(2-(4-(2-(5- chloropyridin-2- yl)-2- methylbenzo[d]...)
Affinity DataEC50:  0.530nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771715(2-(2,5-difluoro-4- (2-methyl-2-(4- (trifluoromethy...)
Affinity DataEC50:  0.620nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771758(2-(4-(2-(4-chloro- 2-fluorophenyl)-2- methylbenzo[...)
Affinity DataEC50:  0.640nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771743(2-(4-(2-(4-cyano- 2-fluorophenyl)-2- methylbenzo[d...)
Affinity DataEC50:  0.690nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771727(2-(4-(2-(4-chloro- 2-fluorophenyl)-2- methylbenzo[...)
Affinity DataEC50:  0.700nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771722(2-(4-(2-(5- chloropyridin-2- yl)-2- methylbenzo[d]...)
Affinity DataEC50:  0.780nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771673(2-(4-(2-(4-chloro- 2-fluorophenyl)-2- methylbenzo[...)
Affinity DataEC50:  0.860nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771671(2-(4-(2-(4-chloro- 2-fluorophenyl)-2- methylbenzo[...)
Affinity DataEC50:  0.970nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771694(2-(4-(2-(4-cyano- 2- fluorophenyl)benzo [d][1,3]di...)
Affinity DataEC50:  1.10nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771700(2-(4-(2-(4-chloro- 2-fluorophenyl)-2- methylbenzo[...)
Affinity DataEC50:  1.20nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771676(2-(4-(2-(5- chloropyridin-2- yl)-2- methylbenzo[d]...)
Affinity DataEC50:  1.70nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771726(2-(4-(2-(5- chloropyridin-2- yl)-2- methylbenzo[d]...)
Affinity DataEC50:  1.70nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771682((S)-2-(4-(2-(4- cyano-2- fluorophenyl)benzo [d][1,...)
Affinity DataEC50:  1.90nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771759(2-(4-(2-(4-chloro- 2-fluorophenyl)-2- methylbenzo[...)
Affinity DataEC50:  1.90nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771749(2-(4-(2-(4-cyano- 2-fluorophenyl)-2- methylbenzo[d...)
Affinity DataEC50:  1.90nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771664(2-(4-(2-(5- chloropyridin-2- yl)-2- methylbenzo[d]...)
Affinity DataEC50:  2.40nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771751(2-(4-(2-(4-cyano- 2-fluorophenyl)-2- methylbenzo[d...)
Affinity DataEC50:  2.40nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771714(2-(4-(2-(4-cyano- 2-fluorophenyl)-2- methylbenzo[d...)
Affinity DataEC50:  2.5nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771721(2-(4-(2-(4-chloro- 2-fluorophenyl)-2- methylbenzo[...)
Affinity DataEC50:  2.5nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771757(2-(4-(2-(4-chloro- 2-fluorophenyl)-2- methylbenzo[...)
Affinity DataEC50:  2.60nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771765(2-[[4-[2-(4-chloro- 2-fluoro-phenyl)- 2-methyl-1,3...)
Affinity DataEC50:  2.80nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771744(2-(4-(2-(4-cyano- 2-fluorophenyl)-2- methylbenzo[d...)
Affinity DataEC50:  3.30nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771764(2-[[4-[2-(4-chloro- 2-fluoro-phenyl)- 2-methyl-1,3...)
Affinity DataEC50:  3.30nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771712(2-(4-(2-(4-chloro- 2- methoxyphenyl)- 2- methylben...)
Affinity DataEC50:  3.80nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771728(2-(4-(2-(5- chloropyridin-2- yl)-5-fluoro-2- methy...)
Affinity DataEC50:  4.30nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771760(3-[[(2R)-1- acetylazetidin-2- yl]methyl]-2-[[4- [2...)
Affinity DataEC50:  4.30nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771666(2-((5-(2-(5- chloropyridin-2- yl)-2- methylbenzo[d...)
Affinity DataEC50:  4.5nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771710(2-(2,6-difluoro-4- (2-(2-fluoro-4- (trifluoromethy...)
Affinity DataEC50:  6.30nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771762(2-[[4-[2-(4-chloro- 2-fluoro-phenyl)- 2-methyl-1,3...)
Affinity DataEC50:  7.10nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771695(2-(4-(2-(4-chloro- 2-fluorophenyl)-2- methylbenzo[...)
Affinity DataEC50:  7.40nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771755(2-(4-(2-(4-chloro- 2-fluorophenyl)-2- methylbenzo[...)
Affinity DataEC50:  8.20nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM771661(1-((1-(2-amino-2- oxoethyl)cyclopro- pyl)methyl)-2...)
Affinity DataEC50:  8.60nMAssay Description:GLP-1R activation by a compound of the present disclosure was quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/1/2026
Entry Details
US Patent

Displayed 1 to 50 (of 114 total ) | Next | Last >>
Jump to: